RetinalGenix Technologies Inc. SEC filings RTGN

RetinalGenix Technologies Inc. has 114 filings in SEC EDGAR's recent list, going back to Feb 16, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (auditor change). The company's fiscal year ends on December 31.

RetinalGenix Technologies Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Feb 25, 2026 —
144 Notice of proposed sale Nov 7, 2025 —
144 Notice of proposed sale Aug 12, 2025 —
144 Notice of proposed sale May 19, 2025 —
144 Notice of proposed sale Feb 5, 2024 —
144 Notice of proposed sale Nov 7, 2023 —
144 Notice of proposed sale Aug 31, 2023 —

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
RTGN (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Petaluma, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1836295

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.